about
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated thro...
Read More
323.58
-3.39
(-1.04%)
745.5K
XNAS Volume
XNAS 25 Sep, 2025 5:30 PM (EDT)
High Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Star
These stocks are bullish in nature, strong in quality and technical aspects, but bad in valuations. Investors need to be cautious on their returns earned.
View Similar
Embed DVM
Insulet Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..